Skip Navigation LinksHome > May 2013 - Volume 35 - Issue 4 > Severe Eosinophilia in Children: A Diagnostic Dilemma
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e318290bf0b
Original Articles

Severe Eosinophilia in Children: A Diagnostic Dilemma

Amshalom, Annat MD*; Lev, Atar MSc*,†; Trakhtenbrot, Luba PhD†,‡; Golan, Hana MD§; Weiss, Batia MD; Amariglio, Ninette PhD†,‡; Rechavi, Gideon MD, PhD; Somech, Raz MD, PhD*,†

Collapse Box


The differential diagnosis of hypereosinophilia includes both primary (clonal and idiopathic) and secondary medical conditions. Here we raise the awareness of physicians to the unusual causes of hypereosinophilic states and describe the molecular assays used in the diagnosis of hypereosinophilia. Two unusual cases of hypereosinophilia in children that were initially misdiagnosed are reported. T-cell receptor gene rearrangement, skewed X inactivation, fluorescence in situ hybridization analysis, and chromosomal karyotyping were used to reach the final correct diagnosis. Both patients displayed significant eosinophilia and were initially misdiagnosed as having parasitic infection. Nonspecific T-cell clonal expansion was diagnosed in 1 patient based on the clonality of the T-cell receptor variable γ-chain and the skewed chromosome inactivation. The second patient was diagnosed with B-lineage acute lymphoblastic leukemia with a translocation (5;14) (q13;q32) that is well known to be associated with hypereosinophilia. The level of awareness to clonal expansion of WBC subsets which can cause hypereosinophilia should be high when evaluating a patient with extreme eosinophilia. Advanced molecular assays to detect clonal expansion should be used to exclude aberrant clonal processes in such patients.

© 2013 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.